Altered drug targets in cancer refer to specific molecules or pathways within cancer cells that have undergone genetic or epigenetic modifications, making them potential points of therapeutic intervention. These targets are crucial for the survival and proliferation of cancer cells, and their identification has enabled the development of targeted therapies, which aim to specifically inhibit the function of these altered molecules.
